Comparison of screening CEDM and MRI for women at increased risk for breast cancer: a pilot study
MS Jochelson, K Pinker, DD Dershaw… - European journal of …, 2017 - Elsevier
Objectives Contrast enhanced digital mammography (CEDM) is a new breast imaging
technology increasingly used in the diagnostic setting but its utility in the pure screening …
technology increasingly used in the diagnostic setting but its utility in the pure screening …
Contrast‐enhanced Digital Mammography: A Single‐Institution Experience of the First 208 Cases
TC Lewis, VJ Pizzitola, ME Giurescu… - The breast …, 2017 - Wiley Online Library
Contrast‐enhanced digital mammography (CEDM) is the only imaging modality that
provides both (a) a high‐resolution, low‐energy image comparable to that of digital …
provides both (a) a high‐resolution, low‐energy image comparable to that of digital …
Contrast-enhanced mammography versus breast magnetic resonance imaging: a systematic review and meta-analysis
Background: Contrast-enhanced mammography (CEM) and contrast-enhanced magnetic
resonance imaging (CE-MRI) are commonly used in the screening of breast cancer. The …
resonance imaging (CE-MRI) are commonly used in the screening of breast cancer. The …
Comparative performance of contrast-enhanced mammography, abbreviated breast MRI, and standard breast MRI for breast cancer screening
Background Contrast-enhanced mammography (CEM) and abbreviated breast MRI (ABMRI)
are emerging alternatives to standard MRI for supplemental breast cancer screening …
are emerging alternatives to standard MRI for supplemental breast cancer screening …
Contrast-enhanced mammography in breast cancer screening
K Coffey, MS Jochelson - European journal of radiology, 2022 - Elsevier
Contrast-enhanced mammography (CEM) is a promising vascular-based breast imaging
technique with high diagnostic performance in detecting breast cancer. Dual-energy …
technique with high diagnostic performance in detecting breast cancer. Dual-energy …
Supplemental breast MR imaging screening of women with average risk of breast cancer
CK Kuhl, K Strobel, H Bieling, C Leutner, HH Schild… - Radiology, 2017 - pubs.rsna.org
Purpose To investigate the utility and accuracy of breast magnetic resonance (MR) imaging
as a supplemental screening tool in women at average risk for breast cancer and to …
as a supplemental screening tool in women at average risk for breast cancer and to …
Performance of dual-energy contrast-enhanced digital mammography for screening women at increased risk of breast cancer
JS Sung, L Lebron, D Keating, D D'Alessio… - Radiology, 2019 - pubs.rsna.org
Background Contrast agent–enhanced digital mammography (CEDM) has been shown to
be more sensitive and specific than two-dimensional full-field digital mammography in the …
be more sensitive and specific than two-dimensional full-field digital mammography in the …
Breast MRI as an adjunct to mammography for breast cancer screening in high-risk patients: retrospective review
A Raikhlin, B Curpen, E Warner… - American Journal of …, 2015 - Am Roentgen Ray Soc
OBJECTIVE. In July 2011, the provincial government of Ontario, Canada, approved funding
for the addition of annual breast MRI to mammography screening for all women 30–69 years …
for the addition of annual breast MRI to mammography screening for all women 30–69 years …
Evaluation of the utility of screening mammography for high-risk women undergoing screening breast MR imaging
G Lo, AM Scaranelo, H Aboras, S Ghai, S Kulkarni… - Radiology, 2017 - pubs.rsna.org
Purpose To evaluate the value of mammography in detecting breast cancer in high-risk
women undergoing screening breast magnetic resonance (MR) imaging. Materials and …
women undergoing screening breast magnetic resonance (MR) imaging. Materials and …
Screening women at high risk for breast cancer with mammography and magnetic resonance imaging
BACKGROUND The authors compared the performance of screening mammography versus
magnetic resonance imaging (MRI) in women at genetically high risk for breast cancer …
magnetic resonance imaging (MRI) in women at genetically high risk for breast cancer …